Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Comment by zwerp2000on Jan 03, 2025 7:02pm
127 Views
Post# 36386946

RE:RE:RE:RE:RE:RE:have dots been connected yet, jd??

RE:RE:RE:RE:RE:RE:have dots been connected yet, jd??You may want to dig deeper, TheTruth1234, so that you might actually stumble upon The Truth.

What is the truth? You're just throwing out comments without backing anything up to suggest that there was really more to the bti story. 

Here's the truth, JD. XB3 was a failure. Yeah, some big pharma companies took a look at it and deemed it useless which is why they all passed on it. This is what many pharma companies do. They look at and test different technologies and if it's worth pursuing they do. If not, they walk away. Look at DYAI. How many big companies/organizations looked at their C1 technology and passed? MANY. It is inconsequential financially to these big companies to test these technologies. They aren't forking over much money, especially in the case with BTI, just to test the technology. that is why big payments were contingent on achieving milestones which were never reached. No doubt if there was any value to XB3, one of these big companies would have bought it. 

I think you already know this but refuse to face reality because then it makes all of your time, postings, blogs, comments completely wrong.....but that is the truth....you were wrong.....so, so wrong.
<< Previous
Bullboard Posts
Next >>